Epizyme, Inc.

NORTHERN TRUST CORP

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/12/2022

Shares

270,917

Value ($000)

398

Weight

0.0%

2013 Q4 - 2022 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/12/2022	398	0.0%	270,917	6/30/2022
2022 Q1	5/13/2022	1,581	0.0%	1,374,522	3/31/2022
2021 Q4	2/8/2022	2,372	0.0%	948,546	12/31/2021
2021 Q3	11/15/2021	4,793	0.0%	936,261	9/30/2021
2021 Q2	8/13/2021	8,064	0.0%	970,351	6/30/2021
2021 Q1	5/12/2021	8,314	0.0%	954,464	3/31/2021
2020 Q4	2/11/2021	10,896	0.0%	1,003,372	12/31/2020
2020 Q3	11/16/2020	12,678	0.0%	1,062,690	9/30/2020
2020 Q2	8/14/2020	17,754	0.0%	1,105,450	6/30/2020
2020 Q1	5/14/2020	14,945	0.0%	963,672	3/31/2020
2019 Q4	2/14/2020	23,419	0.0%	951,952	12/31/2019
2014 Q1	5/14/2014	1,894	0.0%	83,166	3/31/2014
2013 Q4	2/21/2014	1,626	0.0%	78,177	12/31/2013